We are live on !
Find out more
Allianz Asset Management Portfolio holdings
AUM
$123B
Turnover
17.04%
1-Year Est. Return
45.26%
This Fund
S&P 500
This Quarter Est. Return
+20.62%
1 Year Est. Return
+45.26%
3 Year Est. Return
+125.65%
5 Year Est. Return
+152.93%
10 Year Est. Return
+730.98%
AUM
$123B
AUM Growth
+$27.8B
(+29%)
Cap. Flow
+$11.7B
Cap. Flow % of AUM
Cap. Flow %
9.52%
Top 10 Holdings %
Top 10 Hldgs %
25.49%
Holding
2,260
New
268
Increased
1,140
Reduced
651
Closed
117
Avg Time Held
Equity + Options
4.7
years
Top 10 Avg Time Held
Equity + Options
4.4
years
Top 20 Avg Time Held
Equity + Options
3.7
years
Avg Time Held Equity only
5.3
years
Top 10 Avg Time Held Equity only
4.4
years
Top 20 Avg Time Held Equity only
3.7
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$2.76B |
| 2 |
State Street SPDR Portfolio S&P 500 ETF
SPYM
|
+$2.25B |
| 3 |
NVIDIA
NVDA
|
+$1.26B |
| 4 |
Amazon
AMZN
|
+$652M |
| 5 |
Apple
AAPL
|
+$516M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Venture Global Inc
VG
|
+$1B |
| 2 |
Qualcomm
QCOM
|
+$354M |
| 3 |
Johnson & Johnson
JNJ
|
+$192M |
| 4 |
Micron Technology
MU
|
+$166M |
| 5 |
Cboe Global Markets
CBOE
|
+$153M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 26.02% |
| 2 | Miscellaneous | 20.61% |
| 3 | Healthcare | 8.84% |
| 4 | Financials | 8.51% |
| 5 | Consumer Discretionary | 7.44% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
|
1
NVIDIA
NVDA
$4.31T
| $6.02B | 4.88% |
30,069,187
+6,129,853
| +26% | +$1.26B |
2013 Q2
52 quarters
|
|
|
2
Apple
AAPL
$5.1T
| $4.21B | 3.42% |
14,544,356
+1,802,440
| +14% | +$516M |
2013 Q2
52 quarters
|
|
|
3
State Street SPDR Portfolio S&P 500 ETF
SPYM
$183B
| $4.06B | 3.3% |
46,223,571
+26,382,568
| +133% | +$2.25B |
2022 Q3
15 quarters
|
|
|
4
iShares Core S&P 500 ETF
IVV
$873B
| $3.58B | 2.9% |
4,777,691
+3,795,730
| +387% | +$2.76B |
2023 Q2
12 quarters
|
|
5
Microsoft
MSFT
$4.05T
| $3.03B | 2.46% |
8,121,141
+555,475
| +7% | +$225M |
2013 Q2
52 quarters
|
|
6
Alphabet (Google) Class A
GOOGL
$3.54T
| $2.68B | 2.18% |
7,498,538
+405,342
| +6% | +$146M |
2015 Q4
42 quarters
|
|
|
7
Amazon
AMZN
$2.89T
| $2.62B | 2.13% |
10,989,748
+2,597,024
| +31% | +$652M |
2013 Q2
52 quarters
|
|
|
8
Venture Global Inc
VG
$29.5B
| $1.92B | 1.56% |
172,261,658
-79,053,964
| -31% | -$1B |
2025 Q1
5 quarters
|
|
9
Alphabet (Google) Class C
GOOG
$3.52T
| $1.66B | 1.35% |
4,693,417
+309,511
| +7% | +$111M |
2013 Q2
52 quarters
|
|
|
10
Micron Technology
MU
$830B
| $1.63B | 1.33% |
1,414,408
-221,951
| -14% | -$166M |
2013 Q2
52 quarters
|
|
11
Applied Materials
AMAT
$294B
| $1.43B | 1.16% |
1,971,329
+135,018
| +7% | +$62.3M |
2013 Q2
52 quarters
|
|
12
Broadcom
AVGO
$1.53T
| $1.41B | 1.14% |
3,730,615
+456,042
| +14% | +$183M |
2013 Q2
52 quarters
|
|
13
Meta Platforms (Facebook)
META
$1.64T
| $1.3B | 1.05% |
2,306,359
+467,451
| +25% | +$286M |
2013 Q2
52 quarters
|
|
14
AstraZeneca
AZN
$294B
| $1.25B | 1.02% |
6,690,300
+160,339
| +2% | +$30.2M |
2025 Q3
3 quarters
|
|
|
15
Johnson & Johnson
JNJ
$679B
| $1.24B | 1% |
4,865,646
-824,856
| -14% | -$192M |
2013 Q2
52 quarters
|
|
16
Lam Research
LRCX
$277B
| $1.19B | 0.97% |
2,746,179
-211,640
| -7% | -$64.2M |
2013 Q2
52 quarters
|
|
17
Cisco
CSCO
$389B
| $953M | 0.77% |
8,112,214
-901,721
| -10% | -$94.3M |
2013 Q2
52 quarters
|
|
18
JPMorgan Chase
JPM
$908B
| $946M | 0.77% |
2,888,627
-212,388
| -7% | -$66M |
2013 Q2
52 quarters
|
|
19
VICI Properties
VICI
$27.7B
| $837M | 0.68% |
31,527,182
+566,922
| +2% | +$15.9M |
2018 Q1
33 quarters
|
|
20
PUT
iShares MSCI Emerging Markets ETF
EEM
$28.3B
| $821M | 0.67% |
12,003,500
+550,100
| +5% | +$35.9M |
2024 Q1
9 quarters
|
|
21
PUT
iShares Russell 2000 ETF
IWM
$78.5B
| $756M | 0.61% |
2,516,700
-200,300
| -7% | -$56.3M |
2024 Q1
9 quarters
|
|
22
Eli Lilly
LLY
$1.26T
| $694M | 0.56% |
578,634
+73,870
| +15% | +$75.5M |
2013 Q2
52 quarters
|
|
23
TJX Companies
TJX
$152B
| $656M | 0.53% |
4,332,475
+159,735
| +4% | +$25.3M |
2013 Q2
52 quarters
|
|
24
Bristol-Myers Squibb
BMY
$127B
| $655M | 0.53% |
11,363,537
+4,483,673
| +65% | +$257M |
2013 Q2
52 quarters
|
|
25
PUT
Invesco QQQ Trust
QQQ
$461B
| $640M | 0.52% |
869,000
+4,600
| +0.5% | +$3.16M |
2014 Q2
48 quarters
|
|
Similar funds
Allianz Asset Management's Q2 2026 Portfolio in Review
As of Q2 2026, Allianz Asset Management held 2,260 positions worth $123B, up 29% from $95.4B the previous quarter. Its ten largest holdings account for 25% of the portfolio.
Allianz Asset Management deployed $11.7B of net new capital in Q2 2026, opening 268 new positions and adding to 1,140 existing holdings. Its largest new stake was Rocket Lab Corp: 2,187,993 shares worth $222M.
By sector, the portfolio is most concentrated in Technology at 26% of assets, up from 24% a quarter earlier, followed by Miscellaneous and Healthcare.
On the sell side, the largest reduction was Venture Global Inc, an estimated $1B trimmed.
- Allianz Asset Management's largest Q2 2026 buy was Rocket Lab Corp: 2,187,993 shares worth $222M.
- Allianz Asset Management added most to iShares Core S&P 500 ETF in Q2 2026, an estimated $2.76B increase.
- Allianz Asset Management's biggest Q2 2026 reduction was Venture Global Inc, cutting an estimated $1B.
- Allianz Asset Management fully exited CSG Systems International in Q2 2026, selling an estimated $39.2M.
- Allianz Asset Management's ten largest holdings make up 25% of its $123B portfolio in Q2 2026.
- Allianz Asset Management opened 268 new positions and closed 117 in Q2 2026.
- Allianz Asset Management's portfolio value rose 29% quarter-over-quarter to $123B.
Based on Allianz Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.